✦ LIBER ✦

Comparison of the safety and immunogenicity of hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide and a licensed hepatitis B vaccine in healthy young adults

✍ Scribed by Scott A. Halperin; Simon Dobson; Shelly McNeil; Joanne M. Langley; Bruce Smith; Robyn McCall-Sani; Dan Levitt; Gary Van Nest; Daniel Gennevois; Joseph J. Eiden

Book ID: 116958417
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 130 KB
Volume: 24
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2005.08.095

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and immunogenicity of different t

Safety and immunogenicity of different two-dose regimens of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in healthy young adults

✍ Scott A. Halperin; Shelly McNeil; Joanne M. Langley; Bruce Smith; Donna MacKinno 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 283 KB

Comparison of safety and immunogenicity

Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in healthy adults 18–55 years of age

✍ Scott A. Halperin; Brian Ward; Curtis Cooper; Gerald Predy; Francisco Diaz-Mitom 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 344 KB

A phase I study of the safety and immuno

A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant

✍ Scott A Halperin; Gary Van Nest; Bruce Smith; Simin Abtahi; Heather Whiley; Jose 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Immunogenicity and safety of a tetravale

Immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine co-administered with a booster dose of a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzaetype b conjugate vaccine in healthy children aged 12–23

✍ Fred Zepp; Ulrich Behre; Klaus Kindler; Karl-Heinz Laakmann; Heidemarie Pankow-C 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 166 KB

Safety of the 11-valent pneumococcal vac

Safety of the 11-valent pneumococcal vaccine conjugated to non-typeable Haemophilus influenzae-derived protein D in the first 2 years of life and immunogenicity of the co-administered hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio virus, Haemophilus influenzae type b and control hepatitis A vaccines

✍ Roman Prymula; Roman Chlibek; Miroslav Splino; Eva Kaliskova; Igor Kohl; Patrici 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 325 KB